Ramiro Salom
Papers
1
Total Citations
12
H-Index
1
About
Dr. Ramiro Salom is a leading ophthalmology researcher whose work centers on innovative treatments for neovascular age-related macular degeneration (nAMD), a primary cause of blindness. His major contribution is spearheading the pivotal STAR trial, a randomized, double-masked, sham-controlled study evaluating stereotactic radiotherapy for nAMD. This groundbreaking device trial demonstrated that ionizing radiation can effectively mitigate key pathogenic processes underlying the disease, offering a potential alternative to burdensome anti-VEGF injections. With 12 citations since its 2024 publication, the STAR trial has already shaped clinical discussions, highlighting Dr. Salom’s role in advancing non-pharmacological therapies. His research bridges radiation oncology and retinal disease, aiming to reduce treatment frequency and improve patient quality of life. Dr. Salom’s work is notable for its rigorous methodology and potential to transform nAMD management, making him a key figure in ocular therapeutics.
Research Focus
Key Achievements
Top Papers
- 1